< Back to latest news & events

Event

AI IP Europe 2022

October 2022

Event date: 3rd November 2022

HGF is a gold sponsor at the AI IP Europe on 3rd November in Munich.

IAM’s AI IP Europe 2022 will bring together leading experts from industry and private practice for networking opportunities and in-depth discussions on the most pressing AI questions facing IP strategists.

HGF Partner & Patent Attorney Jeff Clarke will be moderating the session on Masterclass: Data: how to manage this increasingly valuable asset.

This session will look at how AI is radically increasing the practical importance and commercial value of data and will enable you to gain a crucial understanding of the best ways to protect and monetise your data.

FIND OUT MORE

 

Attendees

Jeff
Clarke

Latest updates

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

IP Ingredients: The not so "Impossible" Burger

Meat alternatives are a hot topic with the increase in popularity of vegetarianism and veganism, highlighted by this month being “veganuary”.  However, at time when meat alternatives are coming under …

Read article

WTR 1000 2025

We are proud to announce that our European trade mark team has been recognised in the World Trade Mark Review 1000 2025. The firm is also proud to have 19 …

Read article

Court of Appeal Confirms No Second Medical Use SPCs in UK

Merck Serono SA  v  The Comptroller-General of Patents, Designs, and Trade Marks – Lewison LJ, Arnold LJ and Birss LJ – [2025] EWCA Civ 45 – 28 January 2025 The …

Read article

T 0295/22: Apremilast decision highlights hopes and challenges for broad second medical use claims

This case provides insight to the EPO’s interpretation of administration features in second medical use claims. Whilst the door appears to be open for broader second medical use claims, they …

Read article

T 1418/22: Acalabrutinib provides guidance on establishing inventiveness of polymorphs at the EPO

The EPO Board of Appeal’s decision in T 1418/22 gives useful guidance on the inventiveness of polymorph claims in Europe. Starting from a known amorphous form, a specific crystalline form …

Read article

HGF Celebrates Two Nominations at the Women and Diversity in Law Awards

We are proud to share that we have been nominated for two awards at The Women and Diversity in Law Awards which will take place on 18th March at Hilton …

Read article
See all updates